CONTACT US   |  (864) 397-5101

Afaxys Is Now A Public Benefit Corporation

A close-up of a lamp post.

Message from Ronda Dean, President, CEO, & Co-Founder of Afaxys

Afaxys is proud to officially call ourselves a Public Benefit Corporation (PBC). Different from a traditional, solely profit driven corporation, this legal distinction means a corporation will jointly prioritize its social purpose with its need to operate its business successfully; it also creates a strong basis for long-term value creation and mission alignment.

Afaxys, Inc. was founded in 2008 to assure the long-term, well managed supply of mission-critical contraceptives and other medical products for public health family planning providers.

In 2020, as Afaxys’ business matured, our mission expanded to uniquely partner with those who serve public health patients to ensure access to affordable sexual and reproductive healthcare. While our mission has evolved, our true purpose remains steady – to do right by society – particularly for the patients that rely on the public health system safety net for their essential sexual and reproductive healthcare.

As Afaxys looks to the future, we honor our legacy with this Public Benefit Corporation legal distinction.

The public benefit purpose of Afaxys, Inc. is to advance health equity and contribute to a healthier, more empowered society where every individual has the healthcare resources needed to lead the fulfilling life they choose. Afaxys will ensure access to high-quality products for patients served by public health professionals.

Afaxys started out as a group purchasing organization (GPO), solely focused on affordable access and patients served in the public health sector. As our business has grown and evolved, we have enjoyed seeing other companies join the crusade for health equity. Together, we can and will make a difference because we believe sexual and reproductive healthcare should be a right, not a privilege. Thank you for your support and encouragement over the years.

Ronda Dean

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.